Abstract：OBJECTIVE: To study the protective effects of tetramethylpyrazine (TMPZ) on rat myocardial cells infected by Coxsackie virus B3 (CVB3) and its signal transduction mechanism. METHODS: The cultured myocardial cells of neonatal Sprague-Dawley rats were randomly treated with CVB3, CVB3+TMPZ (100 μmol/L), TMPZ (100 μmol/L) (negative control) or DMEM (blank control). After treatment, the beating rate of myocardial cells and the LDH activity in the culture fluid were measured. Cell viability was ascertained with MTT assay. Western blot was used to study the expression of nuclear factor kappa-B (NF-κB) protein in myocardial cells. RESULTS: The beating rate of myocardial cells in the untreated CVB3 infection group was significantly lower than that in the TMPZ-treated CVB3 infection group (32.0±3.6 bpm vs 84.3±3.5 bpm, P<0.01). The LDH activity and NF-κB expression in the TMPZ-treated CVB3 infection group was significantly reduced when compared with untreated CVB3 infection group (P<0.05, P<0.01, respectively). Cell viability 7 days after CVB3 infection in the TMPZ-treated group was higher than that in the untreated CVB3 infection group ［(86.7±2.7)％ vs (35.3±3.4)%; P<0.01］. CONCLUSIONS: TMPZ can provide protective effects on rat myocardial cells infected by CVB3, possibly by an inhibition of the activity of NF-κB in myocardial cells.［Chin J Contemp Pediatr, 2009, 11 (8):687-690］
QIAN Zhao-Xin,HUANG Han,LIN Xiao-Juan. Protective effects of tetramethylpyrazine on rat myocardial cells infected by Coxsackie virus B3 and its signal transduction mechanism[J]. CJCP, 2009, 11(08): 687-690.
［1］Yun SH, Shin JO, Lim BK, Kim KL, Gil CO, Kim DK, et al. Change in the cells that express connective tissue growth factor in acute Coxsackievirus-induced myocardial fibrosis in mouse［J］. Virus Res, 2007, 126(1):62-68.
［2］Moss BL, Gross S, Gammon ST, Vinjamoori A, Worms DP. Identification of a ligand-induced transient refractory period in nuclear factor-kappa B signaling［J］.J Biol Chem, 2008, 283(13):8687-8698.
［5］Esfandiarei M, Boroomand S, Suarez A, Si X, Rahmani M, McManus BM. Coxsackievirus B3 activates nuclear factor kappa B transcription factor via a phosphatidylinositol-3 kinase/protein kinase B-dependent pathway to improve host cell viability［J］.Cell Microbiol, 2007, (10):2358-2371.
［6］Guarner J, Bhatnagar J, Shieh WJ, Nolte KB, Klein D, Gookin MS, et al. Histopathologic, immunohistochemical, and polymerase chain reaction assays in the study of cases with fatal sporadic myocarditis［J］. Hum Pathol, 2007, 38(9):1412-1419.
［8］Stathopoulos GT, Sherrill TP, Han W, Sadikot RT, Yull FE, Blackwell TS, et al. Host nuclear factor-kappa B activation potentiates lung cancer metastasis［J］. Mol Cancer Res, 2008, 6(3):364-371.
［9］Li Q, Guo Y, Tan W, Ou Q, Wu WJ, Sturza D, et al. Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappa B dependent pathway［J］. Circulation, 2007, 116(14):1577-1584.
［10］Lin YC, Shun CT, Wu MS, Chen CC. A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-kappa B［J］. Clin Cancer Res, 2006, 12(23):7165-7173.
［11］Ishinaga H, Jono H, Lim JH, Komatsu K, XU X, Lee J, et al. Synergistic induction of nuclear factor-kappa B by transforming growth factor-beta and tumour necrosis factor-alpha is mediated by protein kinase A-dependent RelA acetylation［J］. Biochem J, 2009, 417(2):583-591.
［12］Huang YL, Kou JP, Ma L, Song JX, BY Yu. Possible mechanism of the anti-inflammatory activity of ruscogenin: role of intercellular adhesion molecule-1 and nuclear factor-kappa B［J］. J Pharmacol Sci, 2008, 108(2):198-205.
